Home

20Med Therapeutics is a Dutch biotechnology company developing innovative solutions for efficient intracellular delivery of (oligo)nucleotide therapeutics (siRNA, miRNA, mRNA, DNA) for treatment of genetic diseases.
20Med's proprietary nanogels are highly innovative nanoparticles, designed with several smart bioresponsive functions making them efficient in transport, cellular uptake, and release of active gene and drug molecules into the cytoplasm of target cells.
20Med Nanogels are flexible in functionalization and their unique properties make them applicable to a broad range of medical therapeutics.
20Med’s internal development program focusses on the use of 20Med nanogels for ocular delivery, in particular for the intracellular delivery of oligonucleotide therapeutics for the treatment of hereditary retinal diseases.


20Med's proprietary nanogels are highly innovative nanoparticles, designed with several smart functions to make them efficient in transport, cellular uptake, and release of active gene and drug molecules into the cytoplasm of target cells.